Seeing Is Believing
Currently out of the existing stock ratings of Prakhar Agrawal, 54 are a BUY (93.1%), 4 are a HOLD (6.9%).
Analyst Prakhar Agrawal, currently employed at CANTOR FITZGERALD, carries an average stock price target met ratio of 42.26% that have a potential upside of 54.47% achieved within 110 days.
Prakhar Agrawal’s has documented 107 price targets and ratings displayed on 21 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on AKRO, Akero Therapeutics at 10-Dec-2025.
Analyst best performing recommendations are on TCRT (ALAUNOS THERAPEUTICS).
The best stock recommendation documented was for DICE (DICE MOLECULES HOLDINGS LLC) at 9/14/2022. The price target of $36 was fulfilled within 27 days with a profit of $16.39 (83.58%) receiving and performance score of 30.96.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 09-Feb-2022
$100
$0.01 (0.01%)
$120
4 years 1 months 25 days ago
(09-Feb-2022)
2/5 (40%)
$6.56 (7.02%)
117
Hold Since 22-Dec-2021
$100
$0.01 (0.01%)
$100
4 years 3 months 7 days ago
(27-Dec-2021)
4/7 (57.14%)
$7.96 (8.65%)
204
Hold Since 15-Dec-2021
$100
$0.01 (0.01%)
$104
4 years 3 months 19 days ago
(15-Dec-2021)
0/2 (0%)
$7.15 (7.70%)
Hold Since 15-Dec-2021
$100
$0.01 (0.01%)
$112
4 years 3 months 19 days ago
(15-Dec-2021)
5/7 (71.43%)
$7.15 (7.70%)
473
Hold Since 15-Dec-2021
$100
$0.01 (0.01%)
$76
4 years 3 months 19 days ago
(15-Dec-2021)
5/6 (83.33%)
$7.15 (7.70%)
448
Which stock is Prakhar Agrawal is most bullish on?
What Year was the first public recommendation made by Prakhar Agrawal?